C0026845||Group III/IV muscle
C0027883||afferents
C0442117||intramuscular
C0444584||whole body
C0086418||humans
C2603343||study
C1148554||determine
C0026845||group III/IV muscle
C0027883||afferents
C0518031||endurance
C1510438||assayed
C0026845||muscle
C0677862||biopsy samples
C0023946||locomotor
C0026845||muscle
C0024090||Lumbar
C1370196||intrathecal
C0015846||fentanyl
C0205099||central
C0348018||projection
C0066908||Î¼-opioid receptor
C0023946||locomotor
C0026845||muscle
C0027883||afferents
C0008976||trial
C0243095||findings
C0205099||central
C0348018||projection
C0026845||group III/IV muscle
C0027883||afferent
C0678663||feedback
C0013126||drive
C0023946||locomotor
C0026845||muscle
C0442117||intramuscular
C3714787||CNS
C1327622||regulate
C0023946||locomotor
C0026845||muscle
C0205100||peripheral
C0015672||fatigue
C0026845||group III/IV muscle
C0027883||afferents
C1327622||regulatory
C0023946||locomotor
C0026845||muscle
C0442117||intramuscular
C0025519||metabo
C0026845||group III/IV muscle
C0027883||afferents
C0442117||intramuscular
C0444584||whole body
C0518031||endurance
C0008976||trials
C2911690||under control conditions
C2911690||control conditions
C0024090||lumbar
C1370196||intrathecal
C0015846||fentanyl
C0023216||lower limb
C0026845||muscle
C0027883||afferent
C0678663||feedback
C0678663||FENT
C0224444||Vastus lateralis
C0026845||muscle
C0677862||biopsies
C0026609||Motoneuronal
C0204709||output was estimated
C0224444||vastus lateralis surface
C0013839||electromyography
C0013839||electromyography
C0442117||intramuscular
C0870883||metabolites
C1148554||determine
C1720784||gas chromatography-mass spectrometry
C0224440||Quadriceps
C0015672||fatigue
C0015808||femoral nerve
C1292856||stimulation
C0026609||motoneuronal
C0678663||FENT
C2911690||control conditions
C0008976||trial
C2911690||control conditions
C0678663||FENT
C0008976||trial
C0442117||intramuscular
C0031603||inorganic phosphate
C0033727||H(+)
C0001459||adenosine diphosphate
C0022924||lactate
C0031634||phosphocreatine
C0678663||FENT
C2911690||control conditions
C0678663||FENT
C2911690||control conditions
C1446409||positively
C0031603||inorganic phosphate
C0444584||whole body
C0026845||group III/IV muscle
C0027883||afferents
C0678663||feedback
C3714787||CNS
C0026609||motoneuronal
C0242692||skeletal muscle
C1327622||regulatory
C0442117||intramuscular
C4022950||abnormal homeostatic
C0805586||challenge
C0205100||peripheral
C0015672||fatigue